Active	Status	Sponsor type	Region	Phase	Filter
4 Active 1 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Shinkai, Masaharu
NCT05172037: Novaferon in Non-hospitalized Adult Patients With Mild COVID-19	Recruiting	3	222	Japan	Novaferon, Placebo	Genova Inc., Tokyo Shinagawa Hospital	Covid19	03/22	06/22
NCT04708158: Novaferon for COVID-19 Treatment Trial (NCTT-005)	Recruiting	3	385	Japan	Novaferon, Placebo	Genova Inc.	Covid19	04/23	04/23
NCT06010173: Evaluation of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children	Recruiting	3	240	Japan	Gadopiclenol, Comparator	Guerbet, Bracco Imaging S.p.A.	Lesion in Body Region, CNS Lesion	11/24	12/24
NCT06568042: Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy	Recruiting	2	450	Europe, Canada, Japan, US, RoW	LY3848575, Placebo	Eli Lilly and Company	Neuropathic Pain, Distal Sensory Polyneuropathy	06/26	09/26